о колледже
план приёма
специальности
живопись
менеджмент
звукотехника
фотография
абитуриентам
живопись
менеджмент
звукотехника
фотография
экзамены
история
литература
математика
физика
химия
преподаватели
ссылки
контакты
новости

Наша поддержка:
© 2009-2012 ФГОУ ВППО ВГИК им. С.А. Герасимова

WHO vaccination recommendations - scientists error or a crime?

While information relating to the recommendations of the World Health Organization (WHO) on vaccines, including hepatitis B remains a secret, in the public domain there is a lot of literature, suggestive of scientific incompetence, wrongdoing, and even criminal offenses.

The use of vaccines is exaggerated, and their toxicity is downplayed.

Thus, influenza vaccine recommendations instill a false impression that the vaccine can prevent infection with avian influenza.

Once in September 1994 in France, according to the WHO recommendations, a campaign was launched on total grafting of hepatitis B, was opened a criminal investigation into the claims of relatives whose loved ones (including children) died after vaccination.

Being a judge is appointed by the French medical expert, I have spent thousands of hours in the study of this subject, and I had access to a variety of confidential documents.

Although the court order my reports can not be made public, some information obtained leaked me, when they were transferred to the judicial process.

Thus, some of my investigation can be seen in publications. The basis of this article is based on an open letter in November 2005 to the Director-General of WHO, which had remained unanswered.

HEPATITIS B: Epidemiology

In February 2004, I read a letter from one of my colleagues from India (1), which referred to the false information disseminated by WHO regarding the epidemiology of hepatitis B in his country.

Although I am not very well informed about the state of health in India, I was struck by the fact that the manipulation of the mechanisms described in the letter (no reference to sources, inappropriate extrapolation monstrous exaggeration) were the same in my country, and in his.

And the results were the same: the proposal to include experts from the hepatitis B vaccination in national vaccination, despite the high cost and unprecedented toxicity of the vaccine (2). At the heart of this desire for total vaccination are incredible mistakes.

In one article, which was published in no less than 10 years after the WHO instigation launched the “information” on the universal immunization program against hepatitis B, two outstanding representative Direction General de la Santé (DGS - French analogue Control and Prevention Center diseases) graciously acknowledged that the number of cases of hepatitis B in France could be assessed properly - the true number could be less than seven times (3).

Interestingly, the average American would have taken seriously the results of the US Census, if they showed that it ranges from 250 million to 1.75 billion people? Can I rely on “experts” who in their assessments, including huge financial costs and threatening newborns and children make mistakes that demographics would look ridiculous? (2,4).

In the same article (3), the authors without the slightest irony recognized that data on chronic liver diseases have been extrapolated from the US reports.

And you need not be an expert in the field of epidemiology to understand that the extrapolation of data on chronic liver disease in the United States on the country of the New Beaujolais or Châteauneuf-du-Pape - in other words, a country with the highest rate of diseases associated with alcohol - not It is an example of scientific rigor.

Another recent example, when an American expert from the WHO said that in India against hepatitis B die 250,000 people. He relied on the model of stratification by region and population groups with different income levels.

Skeptics of India, however, objected that the proposed model has never existed, and initial figures to be “refined” in the direction of a far less alarming assessments (5).

Such techniques (similar to an exaggeration of numbers we have seen in France) should be regarded as an obvious deception, but their publicity did not cause any reaction on the part of WHO.

Despite the obvious falsification and serious consequences for the health of the population of the French campaign (2.6), the Government of India 10 years later decided to include hepatitis B vaccine in the national immunization schedule (7). The decision explicitly based on WHO estimates!

HEPATITIS B: vaccine safety

At the same time, WHO and its “experts” continue to post encouraging information (8) expressly referring to the study of the safety of the vaccine (9), which, according to the official report, dated February 2000, was rejected even by the French side.

It is unfortunate typographical error in the second table of this study (and not corrected, as far as I know) has allowed to reduce by half the growth of multiple sclerosis cases in vaccinated adolescents and young adults.

Such a mistake, of course, was to raise suspicions of fraud.

The promotion of vaccination against hepatitis B WHO apparently only served as a shield for the commercial promotion of vaccines. In particular, the Committee was used for the prevention of viral hepatitis (CPCE), which was created, sponsored by (10) and which have penetrated the vaccine manufacturers.

After September 1998, the information about a serious danger for the first time the campaign received coverage in the French media, VHPB created a group of “experts”, who provided media reassuring conclusions about the vaccine, reflecting the position of the WHO.

However, some participants were incompetent, being only hired employees vaccine manufacturers, and the other self-interest was not taken into consideration.

Five years later, to put an end to public concern due to leakage of data from my first report to the court, the French agency has prepared an “international consensus conference”, even without the knowledge or professionals documented the danger of vaccine (11-15), no person, whose work has initiated work in this area (the author of this article).

The conclusions of this conference, however, were the main argument of the WHO (and CDC) in favor of the safety of hepatitis B vaccine

To analyze the preliminary results of a study by Hernan et al. (16), which is a cornerstone in this regard, the organizers invited RT Chen from the US Centers for Disease Control.

Chen has published dozens of articles denying the majority doubt vaccine safety; He is also a co-author of the study (17), the results of which are directly opposed to the results of Hernan.

A great way to achieve a “consensus” on the conference - to limit the presence of those who agree with the right conclusions.

There was not even a hint of democratic debate, at least for the species. P. Van Damme (the organizer of the Cannes International Congress on hepatitis B control as a threat to public health (18), who had a huge influence on subsequent vaccination policy in France and around the world), was first presented at the Conference as “an epidemiologist from the Control Center and prevention of viral hepatitis WHO in Antwerp. ”

Later, his place of work was called “Public Health and Social Medicine, Center for the Prevention and Control of Viral Hepatitis, WHO, University of Antwerp.” It is important to understand why French parents had to stay in the dark about the details provided by the readers of “The Lancet” in the same time period, namely: “Many authors were principal investigators in vaccine trials and acted as consultants of pharmaceutical companies … Group Chairman , P. Van Damme, spent testing vaccines for several vaccine manufacturers … “(19).

Even more shocking was the death of their cynicism application business manager of a pharmaceutical company, “Beecham”, made by the famous French magazine (20): “We started to raise awareness about hepatitis WHO European experts in in 1988. From that time to 1991, we funded epidemiological studies and came to a scientific consensus about the fact that hepatitis B is a major problem for public health. research has been successful, as in 1991, the WHO issued new recommendations on hepatitis B vaccination. ”

When immunization campaign was in full swing, the official French “experts”, including entering into the DGS, did not hesitate to take part in the unwinding of the vaccine under the guise of “health” of publications co-authored by the businessman (22).

For people around the world will be sad news that the WHO experts are required managers of vaccine manufacturers in order to “recognize” the existence of problems in health care.

Moreover, according to the journalist who conducted the interview, the manufacturer has done everything to prevent the publication of this stunning confession.

BIRD FLU

Awareness of questionable behavior by WHO and its tragic consequences in terms of health and financial costs against a background of another scandal, which also involved the WHO - Avian Influenza.

It turns out that under the flimsy pretext of the need to increase the production capacity of the producers persuaded WHO experts recommend vaccination against ordinary flu, while it is obvious that such immunization can not give any protection against avian influenza.

In both cases, the method was the same. Please file a false alarm about the ineffectiveness of the target vaccination in the case of hepatitis B (22,23) and the need to increase the production of vaccines in the case of avian influenza.

Then persuade the WHO to take action based on false recommendations, emphasizing that everyone at risk of contracting hepatitis B or that the flu is a serious illness that requires mass vaccination.

Now experts have criticized the WHO for the fact that the problem of veterinary medical inflated and not given to national agencies to take appropriate action in relation to animals (24,25), that it would be more efficient and would limit the spread of the epidemic.

In addition, figures for deaths from influenza vaccination (26) together with the problem of hiding information suggests that irresponsible vaccination against influenza killed more people than bird flu.

CONCLUSION

Today there is an urgent need for an independent investigation of the reasons that motivate the WHO recommend measures favorable to pharmaceutical companies, even when these recommendations are based on falsified data and non-scientific facts. It’s time to share the interests of global health and WHO experts.

1796kotok.com/privivka/policy/415-privivochnye-rekomendacii-voz-oshibka-uchenyh-ili-prestuplenie.html

NOTES

1. Puliyel J M. Plea to restore public funding for vaccine development. Lancet 2004; 363: 659.
2. Girard M. Autoimune hazards of hepatitis B vaccine. Autoimmun Rev 2005; 4: 96-100.
3. Antona D, Levy-Bruhl D. Epidemiology of hepatitis B in France at the end of the 20th century. Médecine et Maladies Infectieuses 2003; 33 (SupplA): 33-41.
4. Comenge Y, Girard M. Multiple sclerosis and hepatitis B vaccination: adding the credibility of molecular biology to an unusual level of clinical and epidemiological evidence. Med Hypotheses 2006; 66: 84-86.
5. Puliyel JM. Policy analysis of the use of hepatitis B, Hemophilus influenzae type B, Streptococcus pneumoniae-conjugate and rotavirus vaccine in the national immunization schedules, Health Econ 2004; 13: 1147. Author reply: 1147-1148.
6. Girard M. Hepatitis B universal vaccination: learning from French experience. Red Flags, Aug 10, 2005. Available at: www.redflagsdaily.com/articles/2005_aug10.html Accessed Dec 1, 2005.
7. Anon. Why hepatitis-B vaccine for all? City Express, Oct 12, 2005.
8. VHPB. Response by the World Health Organization’s GACVS to the paper by MA Hernan et al .: Recombinant hepatitis B vaccine and the risk of multiple sclerosis. Viral Hepatitis 2004; 13:11.
9. Zipp F, Weil JG, Einhaupl KM. No increase in demyelinating diseases after hepatitis B vaccination. Nat Med 1999; 5: 964-965.
10. Anon. Good news on hepatitis B vaccination in Europe. Scrip 1997; (2288): 22.
11. Fisher MA, Eklund SA. Hepatitis B vaccine and liver problems in U.S. children less than 6 years old, in 1993 and 1994. Epidemiology 1999; 10: 337-339.
12. Fisher MA, Eklund SA, James SA, Lin XH. Adverse events associated with hepatitis B vaccine in US children less than six years of age, in 1993 and 1994. Ann Epidemiol 2001; 11: 13-21.
13. Geier MR, Geier DA. Hepatitis B vaccination safety. Ann Pharmacother 2002; 36: 370-374.
14. Hernan M, Jick S, Olek M, Jick H. Recombinant hepatitis B vaccine and the risk of multiple sclerosis: a prospective study. Neurology 2004; 63: 838-842.
15. Geier DA, Geier MR. Hepatitis B vaccination and arthritic adverse reactions: a followup analysis of the Vaccine Adverse Events Reporting System (VAERS) database. Clin Exp Rheumatol 2002; 20: 119.
16. Hernan M, Jick S, Olek M, Ascherio A, Jick H. Recombinant hepatitis B vaccine and the risk of multiple sclerosis. Pharmacoepidemol Drug Saf 2003; 12: S59-S60.
17. DeStefano F, Verstraeten T, Jackson LA, et al. Vaccination and risk of central nervous system demyelinationg diseases in adults. Arch Neurol 2003; 60: 504-509.
18. Van Damme P, Kane M. Proceedings of the International Congress. Action towards control of hepatitis B as a community health risk. Cannes, Nov 22-24, 1993. Introduction. Vaccine 1995; vol 13 (suppl 1): S5.
19. Van Damme P, Banatvala J, Fay O, et al. Hepatitis A booster vaccination: is there a need? Lancet 2003; 362: 1065-1071.
20. Labbe C, Le Taillanter M, Recacens O et al. L’abile strategie d’un labo. Sciences et Avenir, January 1997, p 27.
21. Begue P, Denis F, Goudeau A, et al. Vaccination contre l’hepatite B en France. Bilan de la campagne de vaccinations en 1995. La Revue du Praticien, May 12, 1997.
22. Carnall D. Shire Hall Communications and the case for hepatitis B immunization. BMJ 1996; 313: 825.
23. Beeching NJ. Hepatitis B infections. BMJ 2004; 329: 1059-1060.
24. Ress P. International conference “mildly optimistic” about bird flu. BMJ 2005; 331: 1099.
25. Briet S. Bernard Vallat de l’OIE critique l’OMS pour sa gestion de la grippe aviaire. Liberation, Nov 12, 2005.
26. Anon. Denmark highlights report on adverse reactions to flu vaccines. Scrip 2005; (3101) 6.

11 March 2016

««« The Russians began to drink less and smoke live longer and fewer die Zhenya Maltsev of Krasnodar Territory urgently needs money for treatment »»»

Compiled list of universities bushing exam-score, MIPT, Moscow State Institute, HSE ... »»»
In a joint project of RIA Novosti and the HSE
Gerard Depardieu joins a list of 600 cultural figures, threatening Ukraine's security: Now the name of Depardieu forbidden to mention in the media, and his films are removed from the box office »»»
Depardieu was in the list of undesirable persons in Ukraine, which includes 600 cultural figures "from around the world.
In Russia launched the first test system to the risk of developing cancer Screen »»»
The project is implemented Cancer Prevention Foundation "Do not live in vain," the St.
In the Russian Federation will be an experiment to separate from EGE education »»»
Chapter Rosobrnadzor Lyubov Glebova announced the start of the experiment on the separation procedure of the USE (USE) from the Ministry of Education.
In the Russian Federation will be an experiment to separate from EGE education »»»
Chapter Rosobrnadzor Lyubov Glebova announced the start of the experiment on the separation procedure of the USE (USE) from the Ministry of Education.